Company / Operating Margin
Akebia Therapeutics, Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
10.0%
FY2025
5-year range
-85.5% / 10.0%
FY2021-FY2025
Trend
+131.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 8 years, ranging from -8889.9% in FY2018 to 10.0% in FY2025.
Based on SEC 10-K filings.
10.0% in FY2025 with a 5-year CAGR of +95.7%.
Improved from -23.8% to 10.0% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +37.6pp
- 5-Year Change
- +95.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 131.6% year-over-year.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 10.0% | +131.6% |
| FY2024 | -31.5% | -32.6% |
| FY2023 | -23.8% | +13.9% |
| FY2022 | -27.6% | +67.7% |
| FY2021 | -85.5% | +0.3% |
| FY2020 | -85.8% | -102.7% |
| FY2019 | -42.3% | +99.5% |
| FY2018 | -8889.9% | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026